Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Take 2 Films Uses StorageDNA's LTO LTFS Archiving for "Paddington"

GlobeNewswire January 13, 2015

RestorGenex to Present Glioblastoma Data at Keystone Conference on PI 3-Kinase Signaling Pathways in Disease Conference

Business Wire January 13, 2015

Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant

Business Wire January 13, 2015

Research and Markets: The Russian Biopharmaceuticals and Biomedicine Market 2014-2018

Business Wire January 13, 2015

OncoSec Medical Obtains Allowance of Key Patent Application for Intratumoral Delivery of Plasmid IL-15

Business Wire January 13, 2015

Clinical Trial Shows Benefits of Animal-Assisted Therapy in Adult Cancer Patients Undergoing Complex Cancer Treatment with Chemotherapy and Radiation Therapy

PR Newswire January 13, 2015

NeuroInDx, Inc. Unveils UnipicKTM - A New Universal Cell Collection and Tissue Acquisition System Compatible with Most Inverted Microscopes.

Business Wire January 13, 2015

3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco

Business Wire January 13, 2015

Pluristem to Present at Two Cell Therapy Conferences in January 2015

GlobeNewswire January 13, 2015

Pluristem to Present at Two Cell Therapy Conferences in January 2015

GlobeNewswire January 13, 2015

Cellectis and Ohio State University, Through the Ohio State Innovation Foundation, Enter Into Licensing Agreement for Chimeric Antigen Receptor Technology Targeting Multiple Myeloma

Business Wire January 13, 2015

Curing Kids Cancer Gives More Than $1 Million in 2014 to Fight Childhood Cancers

Marketwired January 12, 2015

A World First at the Montreal Heart Institute - Discovery of a personalized therapy for cardiovascular disease

Canada NewsWire January 12, 2015

Pharmacyclics Announces Preliminary 2014 U.S. Net Product Revenue Results and 2015 U.S. Net Product Revenue Outlook

PR Newswire January 12, 2015

Onconova Therapeutics Appoints Dr. Steven M. Fruchtman as Chief Medical Officer

GlobeNewswire January 12, 2015

ProNAi to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Canada NewsWire January 12, 2015

Remarkable Progress Five Years after Haiti Earthquake

PR Newswire January 12, 2015

Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration

GlobeNewswire January 12, 2015

Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome

PR Newswire January 12, 2015

Biosenta Inc. Announces a New Disinfectant, Called "True"

Marketwired January 12, 2015